Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4601)
All Articles published online
|
Publishing Process of This Article
|
Jun 27, 2013 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Mancuso A. Management of hepatocellular carcinoma: Enlightening the gray zones. World J Hepatol 2013; 5(6): 302-310 [PMID: 23805354 DOI: 10.4254/wjh.v5.i6.302] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v5/i6/302.htm |
| Number | Citing Articles |
| 1 |
Andrea Mancuso. Evidence-based medicine and Management of Hepatocellular Carcinoma in Thalassemia. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01542-2
|
| 2 |
|
| 3 |
Bing Han, Chuan Li, Hao Meng, Fernando Gomes Romeiro, Andrea Mancuso, Zhirui Zhou, Giovanni Battista Levi Sandri, Ying Xu, Tao Han, Lei Han, Lichun Shao, Xingshun Qi. Efficacy and safety of external-beam radiation therapy for hepatocellular carcinoma: An overview of current evidence according to the different target population. BioScience Trends 2019; 13(1): 10 doi: 10.5582/bst.2018.01261
|
| 4 |
Bassel Hafez, Bassam Osman, Joelle Chami, Jana Haidar Ahmad, Karim Ataya, Mohamad Jawad Khalife. Management of ruptured hepatocellular carcinoma invading the gastrointestinal tract: A case report. International Journal of Surgery Case Reports 2022; 96: 107330 doi: 10.1016/j.ijscr.2022.107330
|
| 5 |
John C. Wood. Use of Magnetic Resonance Imaging to Monitor Iron Overload. Hematology/Oncology Clinics of North America 2014; 28(4): 747 doi: 10.1016/j.hoc.2014.04.002
|
| 6 |
Ailinh L. Do, Carrie R. Wong, Long H. Nguyen, Vincent G. Nguyen, Huy Trinh, Mindie H. Nguyen. Hepatocellular Carcinoma Incidence in Noncirrhotic Patients With Chronic Hepatitis B and Patients With Cirrhosis of All Etiologies. Journal of Clinical Gastroenterology 2014; 48(7): 644 doi: 10.1097/MCG.0000000000000015
|
| 7 |
Zhiqiang Wu, Wenbo Guo, Song Chen, Wenquan Zhuang. Determinants of pain in advanced HCC patients recieving hepatic artery infusion chemotherapy. Investigational New Drugs 2021; 39(2): 394 doi: 10.1007/s10637-020-01009-x
|
| 8 |
Jin‐Min Kim, Seung‐Hyun Lee, Woo Young Shin, Keon‐Young Lee, Jun Mee Kim, Seung‐Ik Ahn. Intrahepatic recurrence of single nodular hepatocellular carcinoma after surgical resection: an analysis by segmental distribution. ANZ Journal of Surgery 2018; 88(12) doi: 10.1111/ans.14824
|
| 9 |
Ali Mteyrek, Elisabeth Filipski, Catherine Guettier, Alper Okyar, Francis Lévi. Clock gene Per2 as a controller of liver carcinogenesis. Oncotarget 2016; 7(52): 85832 doi: 10.18632/oncotarget.11037
|
| 10 |
Alessandra Mangia, Davide Bellini, Umberto Cillo, Andrea Laghi, Giuseppe Pelle, Vanna Maria Valori, Eugenio Caturelli. Hepatocellular carcinoma in adult thalassemia patients: an expert opinion based on current evidence. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01391-z
|
| 11 |
Javier Tejeda-Maldonado, Ignacio García-Juárez, Jonathan Aguirre-Valadez, Adrián González-Aguirre, Mario Vilatobá-Chapa, Alejandra Armengol-Alonso, Francisco Escobar-Penagos, Aldo Torre, Juan Francisco Sánchez-Ávila, Diego Luis Carrillo-Pérez. Diagnosis and treatment of hepatocellular carcinoma: An update. World Journal of Hepatology 2015; 7(3): 362-376 doi: 10.4254/wjh.v7.i3.362
|
| 12 |
Ali Mteyrek, Elisabeth Filipski, Catherine Guettier, Malgorzata Oklejewicz, Gijsbertus T.J. van der Horst, Alper Okyar, Francis Lévi. Critical cholangiocarcinogenesis control by cryptochrome clock genes. International Journal of Cancer 2017; 140(11): 2473 doi: 10.1002/ijc.30663
|
| 13 |
A. Mancuso. Letter: hepatocellular carcinoma in thalassaemia – emerging issues and challenges for liver transplant. Alimentary Pharmacology & Therapeutics 2014; 40(11-12): 1368 doi: 10.1111/apt.12989
|
| 14 |
Kandasamy Ashokachakkaravarthy, Biju Pottakkat. Mitotic quiescence in hepatic cancer stem cells: An incognito mode. Oncology Reviews 2020; 14(1) doi: 10.4081/oncol.2020.452
|
| 15 |
Andrea Mancuso. Focusing the Controversies in Budd-Chiari Syndrome Management. The International Journal of Gastroenterology and Hepatology Diseases 2022; 1(1) doi: 10.2174/2666290601666210406162525
|
| 16 |
Andrea Mancuso. Budd–Chiari Syndrome Management: Controversies and Open Issues. Diagnostics 2022; 12(11): 2670 doi: 10.3390/diagnostics12112670
|
| 17 |
Audrey E. Ertel, Shimul A. Shah. Surgical Approaches to Hepatocellular Carcinoma. Seminars in Roentgenology 2016; 51(2): 88 doi: 10.1053/j.ro.2016.02.004
|
| 18 |
Hassan M. Moukhadder, Racha Halawi, Maria Domenica Cappellini, Ali T. Taher. Hepatocellular carcinoma as an emerging morbidity in the thalassemia syndromes: A comprehensive review. Cancer 2017; 123(5): 751 doi: 10.1002/cncr.30462
|
| 19 |
Andrea Mancuso. Timing of transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: An Italian hepatologist’s perspective. Journal of Translational Internal Medicine 2017; 5(4): 194 doi: 10.1515/jtim-2017-0033
|
| 20 |
Hassan M. Moukhadder, Joseph E. Roumi, Rayan Bou-Fakhredin, Ali T. Taher. Hepatocellular Carcinoma in a β-Thalassemia Intermedia Patient: Yet Another Case in the Expanding Epidemic. Hemoglobin 2018; 42(1): 58 doi: 10.1080/03630269.2018.1434197
|
| 21 |
Andrea Mancuso. Management of hepatocellular carcinoma in thalassemia and importance of the human factor. Cancer 2017; 123(6): 1071 doi: 10.1002/cncr.30551
|
| 22 |
Andrea Mancuso, Alberto Maringhini. Management of hepatocellular carcinoma recurrence after liver transplant is far from perfect. The American Journal of Surgery 2018; 216(2): 389 doi: 10.1016/j.amjsurg.2017.04.004
|
| 23 |
Antoine Finianos, Charbel Matar, Ali Taher. Hepatocellular Carcinoma in β-Thalassemia Patients: Review of the Literature with Molecular Insight into Liver Carcinogenesis. International Journal of Molecular Sciences 2018; 19(12): 4070 doi: 10.3390/ijms19124070
|
| 24 |
Dejiang Pang, Chengcheng Yang, Chao Li, Yuanfeng Zou, Bin Feng, Lixia Li, Wentao Liu, Qihui Luo, Zhengli Chen, Chao Huang. Polyphyllin II inhibits liver cancer cell proliferation, migration and invasion through downregulated cofilin activity and the AKT/NF-κB pathway. Biology Open 2020; 9(2) doi: 10.1242/bio.046854
|
| 25 |
Yan Wang, Jing Hu, Danhua Xiang, Xinyi Peng, Qingjun You, Yong Mao, Dong Hua, Jian Yin. Targeted nanosystem combined with chemo-photothermal therapy for hepatocellular carcinoma treatment. Colloids and Surfaces A: Physicochemical and Engineering Aspects 2020; 596: 124711 doi: 10.1016/j.colsurfa.2020.124711
|
| 26 |
Andrea Mancuso, Giuseppe Butera, Margherita Rossi, Alberto Maringhini. Hepatocellular carcinoma in thalassemia and other hemoglobinopathies. Cancer 2023; 129(10): 1614 doi: 10.1002/cncr.34735
|